NO991693L - Forbindelser og metoder for diagnose av tuberkulose - Google Patents

Forbindelser og metoder for diagnose av tuberkulose

Info

Publication number
NO991693L
NO991693L NO991693A NO991693A NO991693L NO 991693 L NO991693 L NO 991693L NO 991693 A NO991693 A NO 991693A NO 991693 A NO991693 A NO 991693A NO 991693 L NO991693 L NO 991693L
Authority
NO
Norway
Prior art keywords
tuberculosis
compounds
polypeptides
methods
diagnosis
Prior art date
Application number
NO991693A
Other languages
English (en)
Other versions
NO991693D0 (no
Inventor
Steven G Reed
Yasir A W Skeiky
Davin C Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas S Vedvick
Daniel R Twardzik
Michael J Lodes
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO991693D0 publication Critical patent/NO991693D0/no
Publication of NO991693L publication Critical patent/NO991693L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelser og metoder for diagnostisering av tuberkulose er beskrevet. Forbindelsene tilveiebragt inkluderer polypeptider som inneholder minst en antigendel eller en eller flere M. tuberkuloseproteiner, og DNA-sekvenser som koder for slike polypeptider. Diagnostiske kit som inneholder slike polypeptider eller DNA-sekvenser og en passende deteksjonsreagens kan bli brukt for deteksjon av M. tuberkuloseinfeksjon i pasienter og biologiske prerver. Antistoffer rettet mot slike polypeptider er også tilveiebragt.
NO991693A 1996-10-11 1999-04-09 Forbindelser og metoder for diagnose av tuberkulose NO991693L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72962296A 1996-08-30 1996-08-30
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
PCT/US1997/018214 WO1998016645A2 (en) 1996-10-11 1997-10-07 Compounds and methods for diagnosis of tuberculosis

Publications (2)

Publication Number Publication Date
NO991693D0 NO991693D0 (no) 1999-04-09
NO991693L true NO991693L (no) 1999-06-09

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991693A NO991693L (no) 1996-10-11 1999-04-09 Forbindelser og metoder for diagnose av tuberkulose

Country Status (11)

Country Link
EP (1) EP0934415A2 (no)
JP (1) JP2001500383A (no)
AU (1) AU4750597A (no)
BR (1) BR9712298A (no)
CA (1) CA2268036A1 (no)
CZ (1) CZ126699A3 (no)
IL (2) IL129389A0 (no)
NO (1) NO991693L (no)
PL (1) PL333304A1 (no)
TR (1) TR199901569T2 (no)
WO (1) WO1998016645A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
CA2296419A1 (en) * 1997-07-16 1999-01-28 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
ES2326257T3 (es) 1999-05-04 2009-10-06 The University Of Medicine And Dentistry Of New Jersey Proteinas expresadas por mycobacterium tuberculosis y no por bcg y su utilizacion como reactivos diagnosticos y vacunas.
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
DK1517913T3 (da) * 1999-10-07 2007-06-18 Corixa Corp En Mycobacterium tuberculosis-kodende sekvens til ekspression af heterologe proteiner
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
DE60139963D1 (de) 2000-06-20 2009-10-29 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2003000721A2 (en) 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
CA2453173C (en) 2001-07-04 2013-12-10 Health Protection Agency Mycobacterial antigens expressed during latency
KR100984264B1 (ko) * 2001-07-25 2010-09-30 토소가부시키가이샤 결핵균 검출을 위한 올리고뉴클레오티드 및 방법
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
NZ581306A (en) 2004-11-16 2011-03-31 Crucell Holland Bv Multivalent vaccines comprising recombinant viral vectors
SI2457926T1 (sl) 2005-04-29 2015-01-30 Glaxosmithkline Biologicals S.A. Nov postopek za preprečevanje ali zdravljenje infekcije z M. tuberculosis
ES2534428T3 (es) * 2005-07-26 2015-04-22 Rutgers, The State University Of New Jersey Perfiles de anticuerpos específicos de un estado tuberculoso
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2087128A4 (en) 2006-11-01 2009-11-04 Immport Therapeutics Inc COMPOSITIONS AND METHODS FOR IMMUNOMINANT ANTIGENES
UA110103C2 (uk) 2010-01-27 2015-11-25 Ґлаксосмітклайн Байолоджікалз С.А. Модифікований туберкульозний антиген
CN115746092B (zh) * 2022-08-12 2024-08-13 齐鲁工业大学 具有抗氧化、抗衰老活性的钝顶螺旋藻藻蓝蛋白活性肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
CZ300688B6 (cs) * 1995-09-01 2009-07-15 Corixa Corporation Polypeptid, farmaceutický prostredek a vakcína s jeho obsahem, zpusob prípravy a použití polypeptidu, molekula rekombinantní DNA a její použití, expresní vektor, hostitelská bunka, fúsní porotein a diagnostický kit
CN1154730C (zh) * 1995-09-01 2004-06-23 科里克萨有限公司 用于结核病诊断的化合物和方法

Also Published As

Publication number Publication date
WO1998016645A3 (en) 1998-08-06
CA2268036A1 (en) 1998-04-23
CZ126699A3 (cs) 1999-09-15
AU4750597A (en) 1998-05-11
PL333304A1 (en) 1999-11-22
TR199901569T2 (xx) 2000-12-21
NO991693D0 (no) 1999-04-09
BR9712298A (pt) 2000-10-24
IL121936A0 (en) 1998-03-10
IL129389A0 (en) 2000-02-17
WO1998016645A2 (en) 1998-04-23
EP0934415A2 (en) 1999-08-11
JP2001500383A (ja) 2001-01-16

Similar Documents

Publication Publication Date Title
NO995690L (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
NO20012812D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av chlamydiainfeksjon
DK1307564T3 (da) Forbindelser og fremgangsmåde til behandling og diagnose af chlamydiainfektion
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
NZ518917A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
EP2192128A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
AU7312801A (en) Compositions and methods for the diagnosis and treatment of herpes simplex virusinfection
EP1712629A3 (en) Compounds and methods for diagnosis of tuberculosis
RU96113950A (ru) Способ диагностики тубергкулеза почек
EP1398378A4 (en) IN NEUROBLASTOM ISOLATED NUCLEIC ACIDS
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application